QDEL vs UTHR · rev $2.73B vs P/E 20, rev $1.56B
Quidel Corporation (QDEL) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Quidel Corporation (QDEL) is a medical devices company listed on NASDAQ.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported QDEL revenue for 2025-12-28 was $2.73B. Net income was -$1.13B. Revenue was down 1.9% from 2024-12-29 to 2025-12-28. QDEL currently screens at market cap $895.3M.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
QDEL currently screens at market cap $895.3M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the QDEL and UTHR stock pages for the full models.
Not investment advice.